ARIAD
Pharmaceuticals, Inc. (NASDAQ: ARIA) today announced that it will
present at the Leerink Swann Global Healthcare Conference being held in
New York City. Harvey J. Berger, M.D., chairman and chief executive
officer, will provide an overview of the Company’s business on Thursday,
February 14, at 9:00 a.m. (ET).
The ARIAD presentation at the Leerink Swann Global Healthcare Conference
will be webcast live and can be accessed by visiting the investor
relations section of the Company's website at http://www.ariad.com/investor.
A replay of the presentation will also be available and archived on the
site for three weeks.
About ARIAD
ARIAD Pharmaceuticals, Inc., headquartered in Cambridge, Massachusetts
and Lausanne, Switzerland, is an integrated global oncology company
focused on transforming the lives of cancer patients with breakthrough
medicines. ARIAD is working on new medicines to advance the treatment of
various forms of chronic and acute leukemia, lung cancer and other
difficult-to-treat cancers. ARIAD utilizes computational and structural
approaches to design small-molecule drugs that overcome resistance to
existing cancer medicines. For additional information, visit http://www.ariad.com
or follow ARIAD on Twitter (@ARIADPharm).
